1-218346056-GCACACACACACACACA-GCACACACACACACACACACACACACA

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS1BS2

The NM_003238.6(TGFB2):​c.-630_-621dupACACACACAC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0255 in 145,594 control chromosomes in the GnomAD database, including 53 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.025 ( 53 hom., cov: 28)

Consequence

TGFB2
NM_003238.6 5_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.715

Publications

1 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2-AS1 (HGNC:50628): (TGFB2 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0255 (3706/145594) while in subpopulation EAS AF = 0.0458 (216/4716). AF 95% confidence interval is 0.0408. There are 53 homozygotes in GnomAd4. There are 1696 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High AC in GnomAd4 at 3706 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.-630_-621dupACACACACAC
5_prime_UTR
Exon 1 of 7NP_003229.1P61812-1
TGFB2
NM_001135599.4
c.-630_-621dupACACACACAC
5_prime_UTR
Exon 1 of 8NP_001129071.1P61812-2
TGFB2
NR_138148.2
n.737_746dupACACACACAC
non_coding_transcript_exon
Exon 1 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.-630_-621dupACACACACAC
5_prime_UTR
Exon 1 of 7ENSP00000355897.4P61812-1
TGFB2-AS1
ENST00000774588.1
n.239-678_239-669dupTGTGTGTGTG
intron
N/A
TGFB2-AS1
ENST00000774589.1
n.32-678_32-669dupTGTGTGTGTG
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0254
AC:
3699
AN:
145516
Hom.:
53
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0237
Gnomad AMI
AF:
0.0297
Gnomad AMR
AF:
0.0131
Gnomad ASJ
AF:
0.0100
Gnomad EAS
AF:
0.0458
Gnomad SAS
AF:
0.00615
Gnomad FIN
AF:
0.0211
Gnomad MID
AF:
0.0130
Gnomad NFE
AF:
0.0306
Gnomad OTH
AF:
0.0212
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0255
AC:
3706
AN:
145594
Hom.:
53
Cov.:
28
AF XY:
0.0239
AC XY:
1696
AN XY:
70906
show subpopulations
African (AFR)
AF:
0.0238
AC:
945
AN:
39684
American (AMR)
AF:
0.0131
AC:
193
AN:
14694
Ashkenazi Jewish (ASJ)
AF:
0.0100
AC:
34
AN:
3398
East Asian (EAS)
AF:
0.0458
AC:
216
AN:
4716
South Asian (SAS)
AF:
0.00615
AC:
27
AN:
4392
European-Finnish (FIN)
AF:
0.0211
AC:
203
AN:
9642
Middle Eastern (MID)
AF:
0.0142
AC:
4
AN:
282
European-Non Finnish (NFE)
AF:
0.0306
AC:
2016
AN:
65918
Other (OTH)
AF:
0.0211
AC:
42
AN:
1992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
156
313
469
626
782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00456
Hom.:
1

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.71

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151329324; hg19: chr1-218519398; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.